Dodecansaeure-<1>adamantylamid | 3717-54-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: Dodecansaeure-<1>adamantylamid
• 英文别名: Dodecanoic acid adamantan-1-ylamide；N-(1-adamantyl)dodecanamide
• CAS: 3717-54-2
• 化学式: C₂₂H₃₉NO
• 分子量: 333.558
• InChiKey: FRFKXRWIBACCCN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.4
• 重原子数：
  24
• 可旋转键数：
  11
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.95
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  Dodecansaeure-<1>adamantylamid 在 lithium aluminium tetrahydride 作用下， 以 乙二醇二甲醚 为溶剂， 生成 <1>Adamantyl-dodecyl-amin
  参考文献：
  名称：

  抗病毒药。2.与1-金刚烷胺有关的化合物的构效关系。

  摘要：

  DOI：

  10.1021/jm00288a019
• 作为产物：
  描述：

  1-溴金刚烷 、 十二腈 在 硫酸 作用下， 生成 Dodecansaeure-<1>adamantylamid
  参考文献：
  名称：

  抗病毒药。2.与1-金刚烷胺有关的化合物的构效关系。

  摘要：

  DOI：

  10.1021/jm00288a019

文献信息

• Inhibitors for the Soluble Epoxide Hydrolase
  申请人：HAMMOCK BRUCE D.

  公开号：US20110021448A1

  公开（公告）日：2011-01-27

  Inhibitors of the soluble epoxide hydrolase (sEH) are provided that incorporate multiple pharmacophores and are useful in the treatment of diseases.

  提供了可用于治疗疾病的可溶性环氧酶（sEH）抑制剂，其中包含多个药效团。
• Optimization of Amide-Based Inhibitors of Soluble Epoxide Hydrolase with Improved Water Solubility
  作者：In-Hae Kim、Fenton R. Heirtzler、Christophe Morisseau、Kosuke Nishi、Hsing-Ju Tsai、Bruce D. Hammock

  DOI：10.1021/jm0500929

  日期：2005.5.1

  Soluble epoxide hydrolase (sEH) plays an important role in the metabolism of endogenous chemical mediators involved in the regulation of blood pressure and inflammation. 1,3-Disubstituted ureas with a polar group located on the fifth atom from the carbonyl group of urea function are active inhibitors of sEH both in vitro and in vivo. However, their limited solubility in water and relatively high melting point lead to difficulties in formulating the compounds and poor in vivo efficacy. To improve these physical properties, the effect of structural modification of the urea pharmacophore on the inhibition potencies, water solubilities, octanol/water partition coefficients (log P), and melting points of a series of compounds was evaluated. For murine sEH, no loss of inhibition potency was observed when the urea pharmacophore was modified to an amide function, while for human sEH 2.5-fold decreased inhibition was obtained in the amide compounds. In addition, a NH group on the right side of carbonyl group of the amide pharmacophore substituted with an adamantyl group (such as compound 14) and a methylene carbon present between the adamantyl and amide groups were essential to produce potent inhibition of sEH. The resulting amide inhibitors have 10-30-fold better solubility and lower melting point than the corresponding urea compounds. These findings will facilitate synthesis of sEH inhibitors that are easier to formulate and more bioavailable.
• US7662910B2
  申请人：——

  公开号：US7662910B2

  公开（公告）日：2010-02-16
• US8476043B2
  申请人：——

  公开号：US8476043B2

  公开（公告）日：2013-07-02
• Antiviral agents. 2. Structure-activity relations of compounds related to 1-adamantanamine
  作者：Paul E. Aldrich、Edward C. Hermann、Walter E. Meier、Marvin Paulshock、William W. Prichard、Jack Austin Synder、John C. Watts

  DOI：10.1021/jm00288a019

  日期：1971.6